等待開盤 09-17 09:30:00 美东时间
-0.050
-1.60%
今日重点评级关注:BTIG:维持Kazia Therapeutics"买入"评级,目标价从34美元升至40美元;摩根大通:维持Annexon"超配"评级,目标价从10美元升至14美元
09-02 14:07
Beyond Air, Inc. announced that its management team will participate in the 2026 Cantor Global Healthcare Conference on September 9-11 in New York. A fireside chat will take place on September 10 at 3:55 PM EDT, with a live webcast available on the company’s website, followed by a 90-day replay. Beyond Air is a medical device and biopharmaceutical company focused on using nitric oxide to treat respiratory illnesses, neurological disorders, and so...
09-02 12:00
US stock futures mixed as markets await Fed Chair Warsh’s Jackson Hole speech, with big moves in premarket trading driven by earnings, guidance, and M&A news.
08-28 16:29
Beyond Air ( ($XAIR) ) has shared an update. Beyond Air reported financial resu...
08-19 04:59
Beyond Air 2027财年第一季度营收维持在180万美元,毛利率升至13%,管理层重申了2026日历年800万美元的业绩指引。
08-14 08:45
Beyond Air (NASDAQ:XAIR) reported quarterly losses of $(11.00) per share which missed the analyst consensus estimate of $(9.40) by 17.02 percent. This is a 64.13 percent increase over losses of $(30.67) per share from the same period last year. The company reported quarterly sales of $1.768 million ...
08-13 19:03
Archer Aviation Inc. ($ACHR), an aviation company developing electric and auton...
08-11 16:23
Beyond Air ( ($XAIR) ) has issued an announcement. On April 7, 2026, Beyond Air...
08-07 05:42
Beyond Air, Inc. announced a $30.1 million private placement, including $10.2 million upfront, $10 million short-term warrants, and $10 million long-term warrants. The financing, led by institutional healthcare investors and including directors and officers, will support the commercial launch of the second-generation LungFit PH, pending FDA approval. The warrants have an exercise price of $5.51 per share, with Series A expiring upon FDA approval ...
07-30 11:00
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Beyond Air业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **营收表现:** 2026财年营收达到770万美元,同比增长107%,主要由新医院采用和强劲的客户留存率推动。第四季度营收190万美元,同比增长66%。 **盈利能力:** 毛利润实现30万美元,而上年同期亏损170万美元,实现200万美元的正向转变,标志着重要的盈利里程碑。 **净亏损:** 归属于普通股股东的净亏损为3,320万美元,每股亏损4.01美元,较上年4,660万美元亏损有所改善。 **现金流:** 净现金消耗1,910万美元,同比减少56%。截至20
06-27 12:03